Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.2.0.727
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2015
Dec. 31, 2014
Research and development contract liabilities, related parties $ 81,250 $ 18,436
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 46,875,814 45,483,097
Common stock, shares outstanding 46,875,814 45,483,097
Series A Convertible Preferred Stock [Member]    
Preferred stock, par value $ 0.0001  
Preferred stock, stated value 10.00  
Preferred stock, per share redemption price $ 50  
Preferred stock, shares authorized 175,000  
Preferred stock, shares issued 175,000  
Preferred stock, shares outstanding 175,000  
Preferred stock, aggregate redemption value $ 8,750,000  
Preferred stock, issuable upon conversion 2,187,500